Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (7325)	3/30/1999 11:39:00 AM
From: Jim Lamb	Read Replies (1) \| Respond to of 9523

RESEARCH ALERT-EVEREN lifts Pfizer targets CHICAGO, March 30 (Reuters) - EVEREN Securities said Tuesday it has raised its intermediate and long-term price targets on drug maker Pfizer Inc. ''with increased confidence in the company's EPS potential and depth of its pipeline.'' -- EVEREN says in a report it raised its intermediate, or zero to six month, share price target to $155 from $145 and its long term, or six to 18 month, target to $175 from $160. -- Has stock rated outperform for both intermediate and long term. -- Says expects Pfizer to launch more than nine new products and expand the indications for use for several existing products over the next three to four years. -- Maintains earnings per share estimates of $2.55 for 1999 and $3.15 for 2000. -- Pfizer shares off 5/8 at 140-3/8 in late morning trade on the New York Stock Exchange